Arthur Menezes is a Cardiology physician. OpenAlex indexes 28 publications with 1,370 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1714 W Anklam Rd Ste 104
Tucson, AZ 857452690
Telephone
520-624-8935Registry record last updated 21 Jul 2022.
Industry payments
34 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Kestra Medical Technology Services, Inc.Program year202539 payments
- Novartis Pharmaceuticals CorporationProgram year202532 payments
- CVRx, Inc.Program year20258 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
84.9%Beta blocker17.8%Metoprolol Succinate46%Carvedilol31%Metoprolol Tartrate16%Bisoprolol Fumarate3%Atenolol2%Propranolol Hcl1%Nebivolol Hcl1%Part D<11 patientsStatin16.3%Atorvastatin Calcium73%Pravastatin Sodium13%Rosuvastatin Calcium10%Simvastatin3%Lovastatin1%Part D<11 patients+ 19 more classes in this area
Blood & clotting
10.5%Factor Xa inhibitor7.7%Eliquis56%Xarelto44%Part D≥139 patientsP2Y12 inhibitor1.6%Clopidogrel100%Part D≥76 patients+ 2 more classes in this area
Metabolism & gastrointestinal
4.3%Potassium supplement2%Potassium Chloride100%Part D≥59 patientsProton pump inhibitor1%Omeprazole79%Pantoprazole Sodium21%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The Cardiovascular Effects of Marijuana: Are the Potential Adverse Effects Worth the High?
PubMed
2019 - The Microvascular and Macrovascular Benefits of Fibrates in Diabetes and the Metabolic Syndrome: A review.
PubMed
2019 - Cardiac rehabilitation fitness changes and subsequent survival
European Heart Journal - Quality of Care and Clinical Outcomes
2018 - Significance of Comorbid Psychological Stress and Depression on Outcomes After Cardiac Rehabilitation
The American Journal of Medicine
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”